SR One Capital Management, LP
14 holdingsFiling period: 2026-03-31Current AUM: $1.10Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx, Inc. | 2.35M | $269.4M | $269.4M | 24.55% | -- | 2026-03-31 |
| 2 | MANE | Veradermics, Inc. | 2.40M | $151.7M | $252.2M | 22.98% | -- | 2026-03-31 |
| 3 | ZBIO | Zenas BioPharma, Inc | 5.04M | $98.5M | $158.4M | 14.43% | -- | 2026-03-31 |
| 4 | — | CRISPR Therapeutics AG | 2.04M | $97.0M | $97.0M | 8.84% | -- | 2026-03-31 |
| 5 | DSGN | Design Therapeutics, Inc. | 6.53M | $69.4M | $79.5M | 7.24% | -- | 2026-03-31 |
| 6 | ORIC | ORIC Pharmaceuticals, Inc. | 4.51M | $58.5M | $51.1M | 4.66% | -- | 2026-03-31 |
| 7 | ALMS | Alumis Inc. | 1.96M | $43.2M | $55.4M | 5.04% | -- | 2026-03-31 |
| 8 | MLYS | Mineralys Therapeutics Inc. | 1.56M | $42.4M | $39.9M | 3.64% | -- | 2026-03-31 |
| 9 | SPRY | ARS Pharmaceuticals, Inc. | 4.01M | $32.2M | $20.6M | 1.88% | -- | 2026-03-31 |
| 10 | ORKA | Oruka Therapeutics, Inc | 430.3K | $21.1M | $41.5M | 3.78% | -- | 2026-03-31 |
| 11 | — | Oculis Holding AG | 641.0K | $17.0M | $17.0M | 1.55% | -- | 2026-03-31 |
| 12 | NKTX | Nkarta, Inc. | 3.33M | $7.0M | $7.0M | 0.63% | -- | 2026-03-31 |
| 13 | — | enGene Holdings Inc. | 747.8K | $5.1M | $5.1M | 0.46% | -- | 2026-03-31 |
| 14 | RARE | Ultragenyx Pharmaceutical Inc. | 137.8K | $2.9M | $3.4M | 0.31% | -- | 2026-03-31 |
← Scroll →